TrialScientific reports2025

Prophylactic infusion of donor derived CMV specific T cells for the prevention of CMV reactivation following allogeneic HSCT.

Maryam Barkhordar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.